Advertisement
Screener

Bausch Health Companies Inc. (BHC) Business Combination, Acquisition Related Costs

2.8 / 5 stars · 68/120 Roast Me

Bausch Health Companies Inc. Business Combination, Acquisition Related Costs

Bausch Health Companies Inc. (BHC) reported Business Combination, Acquisition Related Costs of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-07-30

  • Bausch Health Companies Inc. business combination, acquisition related costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Bausch Health Companies Inc. business combination, acquisition related costs for the quarter ending 2026-03-31 was $1.00M, a 0.00% change year-over-year.
  • Bausch Health Companies Inc. business combination, acquisition related costs for the quarter ending 2025-12-31 was $4.00M, a 300.00% increase year-over-year.
  • Bausch Health Companies Inc. business combination, acquisition related costs for the quarter ending 2025-09-30 was $2.00M, a 0.00% change year-over-year.
  • Bausch Health Companies Inc. business combination, acquisition related costs for fiscal 2025 was $9.00M, a 125.00% increase from fiscal 2024.
  • Bausch Health Companies Inc. business combination, acquisition related costs for fiscal 2024 was $4.00M, a 83.33% decline from fiscal 2023.
  • Bausch Health Companies Inc. business combination, acquisition related costs for fiscal 2023 was $24.00M.
  • Bausch Health Companies Inc. business combination, acquisition related costs for fiscal 2022 was $0.00.
Period endBusiness Combination, Acquisition Related Costs 3 monthBusiness Combination, Acquisition Related Costs 3 month as first filedBusiness Combination, Acquisition Related Costs 6 monthBusiness Combination, Acquisition Related Costs 6 month as first filedBusiness Combination, Acquisition Related Costs 9 monthBusiness Combination, Acquisition Related Costs 9 month as first filedBusiness Combination, Acquisition Related Costs 12 monthBusiness Combination, Acquisition Related Costs 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-07-30
$1.00M
10-Q · filed 2026-07-30
$5.00M
derived: sum of 3 quarters · filed 2026-07-30
$7.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$1.00M
10-Q · filed 2026-04-30
$5.00M
derived: sum of 2 quarters · filed 2026-04-30
$7.00M
derived: sum of 3 quarters · filed 2026-04-30
$9.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$6.00M
derived: sum of 2 quarters · filed 2026-02-19
$8.00M
derived: sum of 3 quarters · filed 2026-07-30
$9.00M
10-K · filed 2026-02-19
2025-09-30$2.00M
10-Q · filed 2025-10-30
$4.00M
derived: sum of 2 quarters · filed 2026-07-30
$5.00M
10-Q · filed 2025-10-30
$6.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$2.00M
10-Q · filed 2026-07-30
$3.00M
10-Q · filed 2026-07-30
$4.00M
derived: sum of 3 quarters · filed 2026-07-30
$6.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$1.00M
10-Q · filed 2026-04-30
$2.00M
derived: sum of 2 quarters · filed 2026-04-30
$4.00M
derived: sum of 3 quarters · filed 2026-04-30
$5.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$3.00M
derived: sum of 2 quarters · filed 2026-02-19
$4.00M
derived: sum of 3 quarters · filed 2026-02-19
$4.00M
10-K · filed 2026-02-19
2024-09-30$2.00M
10-Q · filed 2025-10-30
$3.00M
derived: sum of 2 quarters · filed 2025-10-30
$3.00M
10-Q · filed 2025-10-30
$9.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30$1.00M
10-Q · filed 2025-07-31
$1.00M
10-Q · filed 2025-07-31
$7.00M
derived: sum of 3 quarters · filed 2026-02-19
$22.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31$0.00
10-Q · filed 2025-05-01
$6.00M
derived: sum of 2 quarters · filed 2026-02-19
$21.00M
derived: sum of 3 quarters · filed 2026-02-19
$24.00M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$21.00M
derived: sum of 2 quarters · filed 2026-02-19
$24.00M
derived: sum of 3 quarters · filed 2026-02-19
$24.00M
10-K · filed 2026-02-19
2023-09-30$15.00M
10-Q · filed 2024-10-31
$18.00M
derived: sum of 2 quarters · filed 2024-10-31
$18.00M
10-Q · filed 2024-10-31
2023-06-30$3.00M
10-Q · filed 2024-08-01
$3.00M
10-Q · filed 2024-08-01
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$0.00
derived: sum of 2 quarters · filed 2025-02-20
$0.00
derived: sum of 3 quarters · filed 2025-02-20
$0.00
10-K · filed 2025-02-20
$29.00M
10-K · filed 2023-02-23
2022-09-30$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
$0.00
10-Q · filed 2023-11-02
-$5.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$0.00
10-Q · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
-$5.00M
derived: sum of 3 quarters · filed 2024-02-22
$3.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$3.00M
10-Q · filed 2022-05-10
-$5.00M
derived: sum of 2 quarters · filed 2024-02-22
$3.00M
derived: sum of 3 quarters · filed 2024-02-22
$12.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$9.00M
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
$11.00M
10-K · filed 2022-02-23
2021-09-30$8.00M
10-Q · filed 2021-11-02
$17.00M
derived: sum of 2 quarters · filed 2021-11-02
$8.00M
10-Q · filed 2021-11-02
$30.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$9.00M
10-Q · filed 2021-08-03
$0.00
10-Q · filed 2021-08-03
$22.00M
derived: sum of 3 quarters · filed 2023-02-23
$24.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$9.00M
10-Q · filed 2022-05-10
$13.00M
derived: sum of 2 quarters · filed 2023-02-23
$15.00M
derived: sum of 3 quarters · filed 2023-02-23
$26.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$24.00M
derived: sum of 2 quarters · filed 2023-02-23
$35.00M
derived: sum of 3 quarters · filed 2023-02-23
$48.00M
10-K · filed 2023-02-23
$0.00
10-K · filed 2021-02-24
2020-09-30$2.00M
10-Q · filed 2021-11-02
$0.00
10-Q · filed 2020-11-03
$13.00M
derived: sum of 2 quarters · filed 2021-11-02
$26.00M
10-Q · filed 2021-11-02
$0.00
10-Q · filed 2020-11-03
$38.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-06-30$11.00M
10-Q · filed 2021-08-03
$0.00
10-Q · filed 2020-08-06
$24.00M
10-Q · filed 2021-08-03
$0.00
10-Q · filed 2020-08-06
$36.00M
derived: sum of 3 quarters · filed 2022-05-11
$36.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-03-31$13.00M
10-Q · filed 2021-05-04
$0.00
10-Q · filed 2020-05-07
$25.00M
derived: sum of 2 quarters · filed 2022-05-11
$25.00M
derived: sum of 3 quarters · filed 2022-05-11
$25.00M
derived: sum of 4 quarters · filed 2022-05-11
2019-12-31$12.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11
$12.00M
derived: sum of 2 quarters · filed 2022-05-11
$12.00M
derived: sum of 3 quarters · filed 2022-05-11
$20.00M
8-K · filed 2022-05-11
$8.00M
10-K · filed 2020-02-19
2019-09-30$0.00
10-Q · filed 2020-11-03
$0.00
derived: sum of 2 quarters · filed 2020-11-03
$8.00M
10-Q · filed 2020-11-03
$8.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-06-30$0.00
10-Q · filed 2020-08-06
$8.00M
10-Q · filed 2020-08-06
$8.00M
derived: sum of 3 quarters · filed 2021-05-04
$8.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-03-31$8.00M
10-Q · filed 2020-05-07
$8.00M
derived: sum of 2 quarters · filed 2021-05-04
$8.00M
derived: sum of 3 quarters · filed 2021-05-04
$9.00M
derived: sum of 4 quarters · filed 2021-05-04
2018-12-31$0.00
derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04
$0.00
derived: sum of 2 quarters · filed 2021-05-04
$1.00M
derived: sum of 3 quarters · filed 2021-05-04
$1.00M
8-K · filed 2021-05-04
2018-09-30$0.00
10-Q · filed 2019-11-04
$1.00M
derived: sum of 2 quarters · filed 2019-11-04
$1.00M
10-Q · filed 2019-11-04
2018-06-30$1.00M
10-Q · filed 2019-08-06
$1.00M
10-Q · filed 2019-08-06
2018-03-31$0.00
10-Q · filed 2019-05-06
2017-12-31$0.00
10-K · filed 2020-02-19
2016-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$200.00K
derived: sum of 2 quarters · filed 2017-03-01
$200.00K
derived: sum of 3 quarters · filed 2017-03-01
$2.00M
10-K · filed 2017-03-01
2016-09-30$0.00
10-Q · filed 2016-11-09
$0.00
derived: sum of 2 quarters · filed 2016-11-09
$1.80M
10-Q · filed 2016-11-09
$10.40M
derived: sum of 4 quarters · filed 2017-03-01
2016-06-30$0.00
10-Q · filed 2016-08-09
$1.80M
10-Q · filed 2016-08-09
$10.40M
derived: sum of 3 quarters · filed 2017-03-01
$17.40M
derived: sum of 4 quarters · filed 2017-03-01
2016-03-31$1.80M
10-Q · filed 2016-06-07
$10.40M
derived: sum of 2 quarters · filed 2017-03-01
$17.40M
derived: sum of 3 quarters · filed 2017-03-01
$26.90M
derived: sum of 4 quarters · filed 2017-03-01
2015-12-31$8.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$15.60M
derived: sum of 2 quarters · filed 2017-03-01
$25.10M
derived: sum of 3 quarters · filed 2017-03-01
$39.00M
10-K · filed 2017-03-01
$38.50M
10-K · filed 2016-04-29
2015-09-30$7.00M
10-Q · filed 2016-11-09
$16.50M
derived: sum of 2 quarters · filed 2016-11-09
$30.40M
10-Q · filed 2016-11-09
$26.30M
10-Q · filed 2015-10-26
$32.70M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$9.50M
10-Q · filed 2016-08-09
$23.40M
10-Q · filed 2016-08-09
$19.30M
10-Q · filed 2015-07-28
$25.70M
derived: sum of 3 quarters · filed 2017-03-01
$27.30M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$13.90M
10-Q · filed 2016-06-07
$9.80M
10-Q · filed 2015-04-30
$16.20M
derived: sum of 2 quarters · filed 2017-03-01
$17.80M
derived: sum of 3 quarters · filed 2017-03-01
$18.40M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$3.90M
derived: sum of 2 quarters · filed 2017-03-01
$4.50M
derived: sum of 3 quarters · filed 2017-03-01
$6.00M
10-K · filed 2017-03-01
$6.30M
10-K · filed 2015-02-25
2014-09-30$1.60M
10-Q · filed 2015-10-26
$2.20M
derived: sum of 2 quarters · filed 2015-10-26
$3.70M
10-Q · filed 2015-10-26
$15.70M
derived: sum of 4 quarters · filed 2016-04-29
2014-06-30$600.00K
10-Q · filed 2015-07-28
$2.10M
10-Q · filed 2015-07-28
$14.10M
derived: sum of 3 quarters · filed 2016-04-29
$22.70M
derived: sum of 4 quarters · filed 2016-04-29
2014-03-31$1.50M
10-Q · filed 2015-04-30
$13.50M
derived: sum of 2 quarters · filed 2016-04-29
$22.10M
derived: sum of 3 quarters · filed 2016-04-29
$30.00M
derived: sum of 4 quarters · filed 2016-04-29
2013-12-31$12.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
$20.60M
derived: sum of 2 quarters · filed 2016-04-29
$28.50M
derived: sum of 3 quarters · filed 2016-04-29
$36.40M
10-K · filed 2016-04-29
$36.42M
10-K · filed 2014-02-28
2013-09-30$8.60M
10-Q · filed 2014-10-24
$8.65M
10-Q · filed 2013-11-01
$16.50M
derived: sum of 2 quarters · filed 2014-10-24
$24.40M
10-Q · filed 2014-10-24
$24.43M
10-Q · filed 2013-11-01
$77.02M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$7.90M
10-Q · filed 2014-08-01
$7.88M
10-Q · filed 2013-08-07
$15.80M
10-Q · filed 2014-08-01
$15.78M
10-Q · filed 2013-08-07
$68.42M
derived: sum of 3 quarters · filed 2015-02-25
$73.03M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$7.90M
10-Q · filed 2014-05-09
$7.90M
10-Q · filed 2013-05-03
$60.52M
derived: sum of 2 quarters · filed 2015-02-25
$65.13M
derived: sum of 3 quarters · filed 2015-02-25
$79.00M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31$52.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
$57.23M
derived: sum of 2 quarters · filed 2015-02-25
$71.09M
derived: sum of 3 quarters · filed 2015-02-25
$78.60M
10-K · filed 2015-02-25
$78.60M
10-K · filed 2013-02-28
2012-09-30$4.61M
10-Q · filed 2013-11-01
$18.47M
derived: sum of 2 quarters · filed 2013-11-01
$25.98M
10-Q · filed 2013-11-01
$46.07M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$13.87M
10-Q · filed 2013-08-07
$21.37M
10-Q · filed 2013-08-07
$41.46M
derived: sum of 3 quarters · filed 2014-02-28
$50.96M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$7.50M
10-Q · filed 2013-05-03
$27.59M
derived: sum of 2 quarters · filed 2014-02-28
$37.09M
derived: sum of 3 quarters · filed 2014-02-28
$38.96M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$20.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$29.59M
derived: sum of 2 quarters · filed 2014-02-28
$31.46M
derived: sum of 3 quarters · filed 2014-02-28
$32.96M
10-K · filed 2014-02-28
2011-09-30$9.50M
10-Q · filed 2012-11-05
$11.37M
derived: sum of 2 quarters · filed 2012-11-05
$12.87M
10-Q · filed 2012-11-05
$15.52M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$1.87M
10-Q · filed 2012-08-03
$3.38M
10-Q · filed 2012-08-03
$6.02M
derived: sum of 3 quarters · filed 2013-02-28
$34.06M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$1.51M
10-Q · filed 2012-05-04
$4.16M
derived: sum of 2 quarters · filed 2013-02-28
$32.19M
derived: sum of 3 quarters · filed 2013-02-28
$39.77M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$2.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$30.68M
derived: sum of 2 quarters · filed 2013-02-28
$38.26M
derived: sum of 3 quarters · filed 2013-02-28
$38.26M
10-K · filed 2013-02-28
2010-09-30$28.04M
10-Q · filed 2011-11-04
$35.61M
derived: sum of 2 quarters · filed 2011-11-04
$35.61M
10-Q · filed 2011-11-04
2010-06-30$7.58M
10-Q · filed 2011-08-08
$7.58M
10-Q · filed 2011-08-08
2009-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$0.00
derived: sum of 2 quarters · filed 2012-02-29
$5.60M
derived: sum of 3 quarters · filed 2012-02-29
$5.60M
10-K · filed 2012-02-29
2009-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$5.60M
derived: sum of 2 quarters · filed 2010-11-05
$5.60M
10-Q · filed 2010-11-05
2009-06-30$5.60M
10-Q · filed 2010-08-06
$5.60M
10-Q · filed 2010-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42